Redemplo

Active Ingredient(s): Plozasiran Sodium
FDA Approved: * November 18, 2025
Pharm Company: * ARROWHEAD
Category: Cholesterol
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Redemplo 25 mg/.5ml Subcutaneous Injection, Solution
NDC: 84141-025
Labeler:
Arrowhead Pharmaceuticals, Inc.